Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)

This study has been completed.
Sponsor:
Collaborator:
Agenus, Inc.
Information provided by (Responsible Party):
Jennifer Clarke, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00905060
First received: May 18, 2009
Last updated: November 12, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)